Find the latest pharmaceutical market place for formulations enquiry about Ambrisentan on PharmaCompass.com.

Tender// Various Finished Dosage Formulations needed in Romania [ENA15532]

Marius Nasta Pneumoftisiology Institute is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 14-Dec-2022.
1. Selexipag (200 mcg) Film coated Tablets. The required quantity is 12,000 units.
2. Ambrisentan (5 mg) Film coated Tablets. The required quantity is 30,000 units.

Reply

12 Nov 2022

Tender// Various Finished Dosage Formulations needed in France [ENA09813]

UniHA GCS is looking for supplies of Various Finished Dosage Formulations. The suppliers must support this tender with ESPD. The deadline is 24-March-2021.
1. Adrenaline without sulfites (5 mg/ 5 ml) Injection. The required quantity is 1,50,000 units.
2. Alprostadil (0.5 mg/ ml) Solution for Injection. The required quantity is 8,000 units.
3. Ambrisentan (10 mg and 5 mg) Tablets. The required quantity is 2,10,000 units and 2,13,000 units respectively.
4. Rifaximin (550 mg) Film-Coated Tablets. The required quantity is 16,00,000 units.
5. Cimetidine (200 mg) Effervescent Tablets. The required quantity is 4,50,000 units.
6. Dapagliflozin (10 mg) Tablets. The required quantity is 10,000 units.
7. Empagliflozin (10 mg and 25 mg) Film-Coated Tablets. The required quantity is 10,000 units for each.
8. Midodrine (2.5 mg) Tablets. The required quantity is 20,00,000 units.
9. Miglustat (100 mg) Capsules. The required quantity is 80,000 units.
10. Nifedipine (20 mg) Prolonged-Release Tablets. The required quantity is 2,20,000 units.

Reply

25 Feb 2021

Tender// Various Finished Dosage Formulations needed in France [ENA09560]

Valenciennes Hospital Center is looking for supplies of Various Finished Dosage Formulations. The deadline is 12-Feb-2021.
1. Midodrine (2.5 mg) Tablet. The required quantity is 28,8445 units.
2. Ambrisentan (5 mg and 10 mg) Tablet. The required quantity is 8,444 units and 18,845 units respectively.
3. Metronidazole (250 mg and 500 mg) Tablet. The required quantity is 29,900 units and 82,238 units respectively.
4. Cinacalcet (30 mg and 60 mg) Tablet. The required quantity is 29,908 units and 2,977 units respectively.
5. Deferiprone (1000 mg and 500 mg) Tablet. The required quantity is 17,128 units and 19,477 units respectively.
6. Entecavir (0.5 mg and 1 mg) Tablet. The required quantity is 1,948 units and 107 units respectively.
7. Cyamemazine (25 mg) Tablet. The required quantity is 909,429 units.
8. Famotidine (20 mg and 40 mg) Tablet. The required quantity is 3,928 units and 5,256 units respectively.
9. Baclofen (0.05 mg/ ml ampoule and 2 mg/ ml) Injection. The required quantity is 97 units and 801 units respectively.
10. Atovaquone (750 mg/ 5ml) Oral Suspension. The required quantity is 340 units.

Reply

22 Jan 2021

Tender// Various Finished Dosage Formulations needed by Centre Hospitalier de Niort in France [ENA09324]

Centre Hospitalier de Niort is looking for supplies of Various Finished Dosage Formulations. The deadline is 11-Jan-2021.
1. Ascorbic Acid (500 mg) Capsules. The required quantity is 17,950 units.
2. Ambrisentan (5 mg & 10 mg) Capsules. The required quantity is 4,660 and 4,690 units respectively.
3. Fluconazole (100 mg, 200 mg & 400 mg) Injections. The required quantity is 2,860, 1,330 and 580 units respectively.
4. Posaconazole (100 mg) Capsules. The required quantity is 25,700 units.

Reply

21 Dec 2020

Ambrisentan 5 mg tablets needed in Colombia [ENA02764]

A Colombian company incorporated in April 2006 by professionals in the area of health, sales and marketing of the pharmaceutical industry is looking for suppliers of Ambrisentan 5 mg tablets. The volume forecast is: First year - 400 packs x 30 tabs of each strength 5 & 10 mg (30% of the whole Colombian market) | Second Year - 50% of the whole Colombian market.

Reply

28 Nov 2018

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.